Is now the time to reconsider risks, benefits, and limitations of estrogen preparations as a treatment for menstrually related migraine?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Is now the time to reconsider risks, benefits, and limitations of estrogen preparations as a treatment for menstrually related migraine?

Published:2023-04-03 Issue:4 Volume:23 Page:377-388
ISSN:1473-7175
Container-title:Expert Review of Neurotherapeutics
language:en
Short-container-title:Expert Review of Neurotherapeutics

Author:

Tiranini Lara¹,Cucinella Laura¹,Martella Silvia²,Bosoni David¹³,Martini Ellis³,Nappi Rossella E.¹³^ORCID

Affiliation:

1. Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy

2. Unit of Preventive Gynecology, IRCCS European Institute of Oncology, Milan, Italy

3. Research Center for Reproductive Medicine, Gynecological Endocrinology and Menopause, IRCCS San Matteo Foundation, Pavia, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Neurology (clinical),General Neuroscience

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737175.2023.2198705

Reference150 articles.

1. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition

2. The Global Burden of Headache: A Documentation of Headache Prevalence and Disability Worldwide

3. Sex differences in the epidemiology, clinical features, and pathophysiology of migraine

4. Migraine: Epidemiology, Impact, and Risk Factors for Progression

5. Migraine prevalence by age and sex in the United States: A life-span study

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP